Skip to content

Clinical trials

Enrolling by invitation Overweight trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Status: Enrolling by invitation Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20151
20181
20203
20221
20232
20247
202517
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation44

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S3
Centro Universitario de Tlajomulco, Universidad de Guadalajara2
Anita Misra-Hebert1
Asma Yahya1
Bioagile Therapeutics Pvt. Ltd.1
Buchinger Wilhelmi Development & Holding GmbH1
Carmen Dietvorst1
Charles University, Czech Republic1
Chinese Academy of Medical Sciences, Fuwai Hospital1
Erasmus Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight44
Obesity39
Diabetes Mellitus7
Hypertension7
Diabetes Mellitus, Type 26
Dyslipidemias5
Metabolic Syndrome5
Noncommunicable Diseases3
Weight Loss3
Cardiovascular Diseases2

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

  • PLAY2CONTROL Study NCT07556679Completion date change2027-10-31 to 2028-06-30October 18, 2026
  • PLAY2CONTROL Study NCT07556679Status changeNot yet recruiting to Enrolling by invitationOctober 18, 2026

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.